- Home
- IREN vs ARQT Comparison
IREN vs ARQT Comparison
Compare IREN & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IREN
- ARQT
- Stock Information
- Founded
- IREN 2018
- ARQT 2016
- Country
- IREN Australia
- ARQT United States
- Employees
- IREN N/A
- ARQT N/A
- Industry
- IREN EDP Services
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- IREN Technology
- ARQT Health Care
- Exchange
- IREN Nasdaq
- ARQT Nasdaq
- Market Cap
- IREN 2.1B
- ARQT 1.1B
- IPO Year
- IREN 2021
- ARQT 2020
- Fundamental
- Price
- IREN $10.58
- ARQT $8.72
- Analyst Decision
- IREN Strong Buy
- ARQT Buy
- Analyst Count
- IREN 11
- ARQT 6
- Target Price
- IREN $14.90
- ARQT $14.40
- AVG Volume (30 Days)
- IREN 16.7M
- ARQT 1.6M
- Earning Date
- IREN 11-11-2024
- ARQT 11-06-2024
- Dividend Yield
- IREN N/A
- ARQT N/A
- EPS Growth
- IREN N/A
- ARQT N/A
- EPS
- IREN N/A
- ARQT N/A
- Revenue
- IREN $188,758,000.00
- ARQT $132,062,000.00
- Revenue This Year
- IREN $154.63
- ARQT $185.11
- Revenue Next Year
- IREN $32.36
- ARQT $48.43
- P/E Ratio
- IREN N/A
- ARQT N/A
- Revenue Growth
- IREN 149.98
- ARQT 1032.90
- 52 Week Low
- IREN $2.79
- ARQT $1.76
- 52 Week High
- IREN $15.75
- ARQT $13.17
- Technical
- Relative Strength Index (RSI)
- IREN 59.44
- ARQT 39.69
- Support Level
- IREN $8.42
- ARQT $8.32
- Resistance Level
- IREN $11.35
- ARQT $8.97
- Average True Range (ATR)
- IREN 0.71
- ARQT 0.48
- MACD
- IREN 0.17
- ARQT -0.04
- Stochastic Oscillator
- IREN 69.11
- ARQT 33.16
About IREN Iris Energy Limited
Iris Energy Ltd is a Bitcoin mining company. It builds, owns, and operates data centers and electrical infrastructure for the mining of Bitcoin powered by renewable energy. The company's mining operations generate revenue by earning Bitcoin through a combination of block rewards and transaction fees from the operation of its specialized computers called Application-specific Integrated Circuits and exchanging these Bitcoin for currencies such as USD or CAD on a daily basis.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.